益气活血药对慢性肺源性心脏病患者免疫功能的影响  

The Influence of Qi-Benefiting and Blood-Circulation-Activating Drugs on the Immunologic Function in Chronic Pulmonary Heart Disease

作　　者：何德平 许坚 林琳 

机构地区：[1]广州中医药大学第二附属医院,广东广州510120

出　　处：《新中医》2001年第12期22-23,共2页New Chinese Medicine

摘　　要：目的:探讨中药益气活血药对慢性肺源性心脏病患者免疫功能的影响。方法:将62例肺心病急性期患者随机分为2组(治疗组32例,对照组30例),均采用西医常规方法治疗,治疗组加用黄芪注射液、复方丹参注射液。观察治疗前后T淋巴细胞亚群变化情况。结果:治疗组治疗前后比较,除CD8外,差异均有非常显著性意义(P<0.01)。对照组治疗前后比较,无统计学意义。结论:益气活血药对肺心病急性发作期有免疫增强和免疫调节作用,从而达到改善症状和缩短病程的目的。Objective:To explore the influence of qi-benefiting,blood-circulation activating drugs on the immunologic function in chronic pulmonary heart disease(PHD).Methods:62 cases of acute stage of PHD were allocated to treatment group(32 cases) and control group (30 cases);routine treatment were given for both groups,and Salviae Miltiorrhizae Injection and Astragali Injection Co.were added in the treatment group.The changes of subgroup of T lymphocytes were observed before and after treatment.Results:The comparison before and after treatment(except CD8)showed markedly significant difference(P < 0.01) in the treatment group,but no difference in the control group.Conclusion:Qi-benefiting and blood-circulation-activating drugs can regulate the immunologic function in the acute stage of pulmonary heart disease,so as to alleviate the symptoms and shorten the treatment course.

关 键 词：肺心病 中西医结合疗法 补气药 活血祛瘀药 免疫系统 

分 类 号：R541.5[医药卫生—心血管疾病]